Baxter Total Long-Term Assets 2010-2025 | BAX

Baxter total long-term assets from 2010 to 2025. Total long-term assets can be defined as the sum of all assets classified as non-current
  • Baxter total long-term assets for the quarter ending March 31, 2025 were $14.269B, a 22.4% decline year-over-year.
  • Baxter total long-term assets for 2024 were $16.929B, a 9.35% decline from 2023.
  • Baxter total long-term assets for 2023 were $18.676B, a 7.89% decline from 2022.
  • Baxter total long-term assets for 2022 were $20.276B, a 17.74% decline from 2021.
Baxter Annual Total Long-Term Assets
(Millions of US $)
2024 $16,929
2023 $18,676
2022 $20,276
2021 $24,649
2020 $11,608
2019 $10,690
2018 $9,761
2017 $9,848
2016 $8,972
2015 $9,166
2014 $15,976
2013 $15,029
2012 $11,130
2011 $10,423
2010 $9,500
2009 $9,083
Baxter Quarterly Total Long-Term Assets
(Millions of US $)
2025-03-31 $14,269
2024-12-31 $16,929
2024-09-30 $17,812
2024-06-30 $17,719
2024-03-31 $18,388
2023-12-31 $18,676
2023-09-30 $18,622
2023-06-30 $19,680
2023-03-31 $20,192
2022-12-31 $20,276
2022-09-30 $20,155
2022-06-30 $23,949
2022-03-31 $24,543
2021-12-31 $24,649
2021-09-30 $11,640
2021-06-30 $11,678
2021-03-31 $11,610
2020-12-31 $11,608
2020-09-30 $11,065
2020-06-30 $10,899
2020-03-31 $10,742
2019-12-31 $10,690
2019-09-30 $10,089
2019-06-30 $10,326
2019-03-31 $10,263
2018-12-31 $9,761
2018-09-30 $9,819
2018-06-30 $9,688
2018-03-31 $9,934
2017-12-31 $9,848
2017-09-30 $10,093
2017-06-30 $9,259
2017-03-31 $9,026
2016-12-31 $8,972
2016-09-30 $9,206
2016-06-30 $9,159
2016-03-31 $9,333
2015-12-31 $9,166
2015-09-30 $9,034
2015-06-30 $15,518
2015-03-31 $15,127
2014-12-31 $15,976
2014-09-30 $15,932
2014-06-30 $16,142
2014-03-31 $15,873
2013-12-31 $15,029
2013-09-30 $15,653
2013-06-30 $11,566
2013-03-31 $11,504
2012-12-31 $11,130
2012-09-30 $10,720
2012-06-30 $10,398
2012-03-31 $10,667
2011-12-31 $10,423
2011-09-30 $9,841
2011-06-30 $9,932
2011-03-31 $9,652
2010-12-31 $9,500
2010-09-30 $9,423
2010-06-30 $9,112
2010-03-31 $9,151
2009-12-31 $9,083
2009-09-30 $8,890
2009-06-30 $8,671
2009-03-31 $8,263
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $15.652B $10.636B
Baxter International Inc. is a global medical technology company. The company consists of renal and hospital products, providing items such as kidney-dialysis equipment, infusion pumps, and intravenous (IV) solutions. Baxter has been reporting through six revenue segments. Renal Care, Medication Delivery, Pharmaceuticals, Clinical Nutrition, Advanced Surgery, Acute Therapies and Other. Baxter's Renal segment primarily consists of Peritoneal Dialysis (PD) and Hemodialysis (HD) therapies. The portfolio addresses the needs of patients with kidney failure or kidney disease, and their healthcare providers, with a comprehensive range of therapeutic options across home, in-center, and hospital settings for better individualized care.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $232.407B 27.95
Boston Scientific (BSX) United States $155.727B 38.99
Stryker (SYK) United States $146.049B 30.54
EssilorLuxottica (ESLOY) France $127.608B 0.00
Medtronic (MDT) Ireland $106.425B 15.09
Haleon (HLN) United Kingdom $51.105B 29.10
Lonza Group Ag (LZAGY) Switzerland $50.009B 0.00
ResMed (RMD) United States $35.893B 26.96
GE HealthCare Technologies (GEHC) United States $32.299B 15.34
Agilent Technologies (A) United States $31.909B 20.73
Terumo (TRUMY) Japan $27.168B 35.29
Insulet (PODD) United States $22.874B 89.79
Koninklijke Philips (PHG) Netherlands $21.656B 15.57
Zimmer Biomet Holdings (ZBH) United States $18.236B 11.71
Smith & Nephew SNATS (SNN) United Kingdom $12.683B 0.00
Sunny Optical Technology (SNPTF) China $9.032B 0.00
Demant (WILYY) Denmark $8.637B 0.00
Bio-Rad Laboratories (BIO) United States $6.175B 21.49
Lantheus Holdings (LNTH) United States $5.228B 13.19
Prestige Consumer Healthcare (PBH) United States $4.233B 18.91
Perrigo (PRGO) Ireland $3.680B 9.33
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
ICU Medical (ICUI) United States $3.319B 24.48
Haemonetics (HAE) United States $3.253B 14.82
Envista Holdings (NVST) United States $3.097B 25.73
GN Store Nord (GNNDY) Denmark $2.224B 18.42
QuidelOrtho (QDEL) United States $2.074B 14.27
LeMaitre Vascular (LMAT) United States $1.857B 41.51
AtriCure (ATRC) United States $1.711B 0.00
Acuren (TIC) United States $1.276B 0.00
Neogen (NEOG) United States $1.272B 16.28
AdaptHealth (AHCO) United States $1.212B 12.30
Kestra Medical Technologies (KMTS) United States $1.156B 0.00
Green Thumb Industries (GTBIF) United States $1.109B 24.95
BioLife Solutions (BLFS) United States $1.039B 0.00
Phibro Animal Health (PAHC) United States $0.990B 12.65
InMode (INMD) Israel $0.927B 9.34
CeriBell (CBLL) United States $0.608B 0.00
Evolus (EOLS) United States $0.593B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.573B 0.00
Curaleaf Holdings (CURLF) Canada $0.550B 0.00
Valneva SE (VALN) France $0.535B 0.00
Owens & Minor (OMI) United States $0.510B 4.23
Capricor Therapeutics (CAPR) United States $0.452B 0.00
Tilray Brands (TLRY) Canada $0.428B 0.00
Surmodics (SRDX) United States $0.415B 0.00
SEMPERIT AG HLD (SEIGY) Austria $0.366B 0.00
SNDL (SNDL) Canada $0.334B 0.00
VAREX IMAGING (VREX) United States $0.316B 11.62
Aurora Cannabis (ACB) Canada $0.298B 53.00
Cresco Labs (CRLBF) United States $0.295B 0.00
Viemed Healthcare (VMD) United States $0.263B 22.17
Sanara MedTech (SMTI) United States $0.258B 0.00
ZimVie (ZIMV) United States $0.255B 11.57
Cerus (CERS) United States $0.243B 0.00
Canopy Growth (CGC) Canada $0.243B 0.00
Verano Holdings (VRNOF) United States $0.229B 0.00
Sanuwave Health (SNWV) United States $0.224B 0.00
OraSure Technologies (OSUR) United States $0.215B 0.00
Quanterix (QTRX) United States $0.202B 0.00
Brainsway (BWAY) Israel $0.193B 51.00
Biote (BTMD) United States $0.189B 5.32
TriSalus Life Sciences (TLSI) United States $0.189B 0.00
High Tide (HITI) Canada $0.182B 0.00
Omeros (OMER) United States $0.181B 0.00
Organigram Global (OGI) Canada $0.181B 0.00
Utah Medical Products (UTMD) United States $0.179B 14.57
Exagen (XGN) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.137B 0.00
Jin Medical (ZJYL) China $0.118B 0.00
TerrAscend (TSNDF) Canada $0.107B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.096B 0.00
Fonar (FONR) United States $0.090B 11.60
Agape ATP (ATPC) $0.087B 0.00
MacroGenics (MGNX) United States $0.086B 0.00
Quipt Home Medical (QIPT) United States $0.078B 0.00
Veru (VERU) United States $0.074B 0.00
InterCure (INCR) Israel $0.071B 0.00
Zynex (ZYXI) United States $0.071B 0.00
Apyx Medical (APYX) United States $0.059B 0.00
Jushi Holdings (JUSHF) United States $0.059B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Cytosorbents (CTSO) United States $0.053B 0.00
United Health Products (UEEC) United States $0.052B 0.00
Modular Medical (MODD) United States $0.047B 0.00
United-Guardian (UG) United States $0.038B 13.18
Rockwell Medical (RMTI) United States $0.034B 0.00
Nephros (NEPH) United States $0.029B 38.86
Safety Shot (SHOT) United States $0.021B 0.00
Allurion Technologies (ALUR) United States $0.020B 0.00
INLIF (INLF) $0.017B 0.00
Flora Growth (FLGC) United States $0.015B 0.00
IM Cannabis (IMCC) Canada $0.014B 0.00
Cellectar Biosciences (CLRB) United States $0.012B 0.00
Trinity Biotech (TRIB) Ireland $0.012B 0.00
Meihua Medical Technologies (MHUA) China $0.011B 0.00
Innovative Eyewear (LUCY) United States $0.010B 0.00
Senestech (SNES) United States $0.005B 0.00
GlucoTrack (GCTK) United States $0.004B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00